Economides, Minas P.
Rizzieri, David
Pemmaraju, Naveen
Article History
First Online: 18 December 2019
Compliance with Ethical Standards
:
: Minas P. Economides declares no conflict of interest.David Rizzieri declares the following: advisory and consultative work with Immunogen, Mustang Bioscience, Stemline; honoraria from Stemline.Naveen Pemmaraju declares the following: consulting/honorarium from Celgene, Stemline, Incyte Corporation, Novartis, MustangBio, Roche Diagnostics, and LFB. Research funding/clinical trials support from Stemline, Novartis, Abbvie, Samus, Cellectis, Plexxikon, Daiichi-Sankyo, Affymetrix, and SagerStrong Foundation.
: This article does not contain any studies with human or animal subjects performed by any of the authors.